Novavax News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

24.11.21	Novavax Files For Interim Authorization Of COVID-19 Vaccine In Singapore - Quick Facts (RTTNews)
24.11.21	Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore (PR Newswire)
23.11.21	Novavax to Participate in Evercore ISI's 4th Annual HealthCONx Virtual Conference (PR Newswire)
17.11.21	Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization (PR Newswire)
17.11.21	Novavax, Serum Institute Of India Receive Emergency Nod For COVID-19 Vaccine In Philippines (RTTNews)
17.11.21	Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines (PR Newswire)
15.11.21	Novavax: SK Bioscience Submits BLA For COVID-19 Vaccine Candidate, NVX-CoV2373, To South Korea' MFDS (RTTNews)
15.11.21	Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373 (PR Newswire)
04.11.21	Novavax Inc. Q3 Earnings Summary (RTTNews)
04.11.21	Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights (PR Newswire)
04.11.21	Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization (PR Newswire)
03.11.21	Novavax Files For Provisional Approval Of COVID-19 Vaccine In New Zealand (RTTNews)
03.11.21	Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand (PR Newswire)
03.11.21	NVAX INVESTOR NEWS: ROSEN, A TOP RANKED LAW FIRM, Encourages Novavax, Inc. Investors with Losses to Inquire About Class Action Investigation - NVAX (PR Newswire)
01.11.21	Novavax, Serum Institute Of India Get EUA For COVID-19 Vaccine In Indonesia (RTTNews)
01.11.21	Novavax Files For COVID-19 Vaccine Authorization In Canada; Submits For Rolling Review To EMA (RTTNews)
01.11.21	Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia (PR Newswire)
01.11.21	Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency (PR Newswire)
29.10.21	Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia (PR Newswire)
27.10.21	Novavax Files For Conditional Marketing Authorization Of COVID-19 Vaccine In The U.K. (RTTNews)
27.10.21	Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom (PR Newswire)
20.10.21	Pre-market Movers: TRKA, NVAX, SESN, HX, BBIG… (RTTNews)
18.10.21	Novavax to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights on November 4, 2021 (PR Newswire)
15.10.21	Novavax to Participate in World Vaccine Congress Europe (PR Newswire)
04.10.21	Novavax Announces Leadership Appointment and Updates (PR Newswire)
29.09.21	Novavax to Participate in Health Equity and Vaccine Confidence Panel at Maryland Life Sciences Bio Innovation Conference (PR Newswire)
24.09.21	Novavax Hosts HM King Carl XVI Gustaf and HM Queen Silvia of Sweden During Royal Visit to Uppsala County (PR Newswire)
24.09.21	Novavax's NanoFlu Influenza Vaccine Phase 3 Trial Meets All Primary Endpoints (RTTNews)
24.09.21	Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases (PR Newswire)
23.09.21	Novavax Announces Submission Of COVID-19 Vaccine To WHO For Emergency Use Listing (RTTNews)
23.09.21	Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine (PR Newswire)
23.09.21	Novavax to Participate in Fireside Chat at the 2021 Cantor Virtual Global Healthcare Conference (PR Newswire)
20.09.21	Novavax to Participate in Fireside Chat at Devex @ UNGA 76 (PR Newswire)
17.09.21	Novavax To Participate In Oxford University Study Comparing Mixed COVID-19 Vaccine (RTTNews)
17.09.21	Novavax to Participate in University of Oxford Com-COV3 Study Comparing Mixed COVID-19 Vaccine Schedule in Adolescents (PR Newswire)
09.09.21	Novavax to Participate in Upcoming September Conferences (PR Newswire)
08.09.21	Novavax Initiates Phase 1/2 Study Of Combination Vaccine For COVID-19 & Influenza - Quick Facts (RTTNews)
08.09.21	Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza (PR Newswire)
07.09.21	Novavax to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021 (PR Newswire)
31.08.21	CDC Considers Novavax COVID-19 Vaccine Trial Participants As Fully Vaccinated Two Weeks After Dosing (RTTNews)
30.08.21	Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants (PR Newswire)
25.08.21	OCTAVE-DUO Study To Evaluate Novavax' Vaccine Candidate In Participants With Impaired Immune Systems (RTTNews)
25.08.21	Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems (PR Newswire)
16.08.21	Novavax Names Jim Kelly CFO; Appoints Nasir Egal As SVP, Quality Assurance (RTTNews)
16.08.21	Novavax Appoints Biopharmaceutical Veterans Jim Kelly as Chief Financial Officer and Nasir Egal, Ph.D., as Senior Vice President of Quality Assurance (PR Newswire)
07.08.21	Novavax gibt Daten zum COVID-19-Auffrischimpfung bekannt, die einen vierfachen Anstieg der neutralisierenden Antikörperspiegel im Vergleich zu den Spitzenwerten nach der Erstimpfung belegen (PR Newswire)
07.08.21	Novavax und Serum Institute of India kündigen Antrag auf Notfallzulassung des rekombinanten Nanopartikel-COVID-19-Impfstoffs von Novavax bei den Zulassungsbehörden in Indien, Indonesien und auf de... (PR Newswire)
05.08.21	Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination (PR Newswire)
05.08.21	Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine (PR Newswire)
05.08.21	EARNINGS SUMMARY: Details of Novavax Inc. Q2 Earnings Report (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

29.11.24		Pluszeichen in New York: Letztendlich Gewinne im Dow Jones
29.11.24		Starker Wochentag in New York: Dow Jones mit Kursplus
29.11.24		Börse Zürich in Grün: SLI letztendlich in der Gewinnzone
29.11.24		Aufschläge in London: FTSE 100 schlussendlich im Aufwind
29.11.24		Gewinne in Europa: Euro STOXX 50 präsentiert sich zum Ende des Freitagshandels fester
29.11.24		SMI-Handel aktuell: SMI zum Handelsende auf grünem Terrain

29.11.24

Pluszeichen in New York: Letztendlich Gewinne im Dow Jones

29.11.24

Starker Wochentag in New York: Dow Jones mit Kursplus

29.11.24

Börse Zürich in Grün: SLI letztendlich in der Gewinnzone

29.11.24

Aufschläge in London: FTSE 100 schlussendlich im Aufwind

29.11.24

Gewinne in Europa: Euro STOXX 50 präsentiert sich zum Ende des Freitagshandels fester

29.11.24

SMI-Handel aktuell: SMI zum Handelsende auf grünem Terrain